Relative safety of pooled whole blood-derived versus single-donor (apheresis) platelets in the United States: a systematic review of disparate risks.
about
Meta-analysis of the studies of bleeding complications of platelets pathogen-reduced with the Intercept system.Angiotensin 1 - 7 stimulation of platelet recovery.Impact of platelet transfusion on toxicity and mortality after hematopoietic progenitor cell transplantation.I am the 9%: Making the case for whole-blood platelets.The Effect of Intravenous Administration of Active Recombinant Factor VII on Postoperative Bleeding in Cardiac Valve Reoperations; A Randomized Clinical Trial.Supportive care in patients with acute leukaemia: historical perspectives.The Leukocyte Antibody Prevalence Study-II (LAPS-II): a retrospective cohort study of transfusion-related acute lung injury in recipients of high-plasma-volume human leukocyte antigen antibody-positive or -negative components.Toward a patient-based paradigm for blood transfusion.Safety of platelet transfusion: past, present and future.Detection of bacterial contamination in apheresis platelets: is apheresis technology a factor?Reasons for moving toward a patient-centric paradigm of clinical transfusion medicine practice.Implications of a switch to a 100% apheresis platelet supply for patients and for blood donors: a risk benefit analysis.The association between platelet transfusion and idiopathic pneumonia syndrome is unaffected by platelet product type.Allergic transfusion reactions to platelets are more commonly associated with prepooled than apheresis components.Perioperative Single-Donor Platelet Apheresis and Red Blood Cell Transfusion Impact on 90-Day and Overall Survival in Living Donor Liver Transplantation.2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery.Optimizing transfusion strategies in damage control resuscitation: current insights
P2860
Q33397396-6C7CC688-D89A-496D-A2B2-C544CBEAA276Q33413442-81B83033-0CF6-4C92-B2BD-984170AE3C93Q33417080-CB5389F3-4836-4B16-9FA2-0E0D3143DACCQ33432190-DD793775-01B3-4C9E-AA95-48C016FCB0BFQ35148987-FC1B1256-F3E5-4DD0-B1D9-E6D16BC4629BQ35265135-18B15824-A39D-420E-9FA0-F6D013E3B71CQ36709660-C96E6B6C-B7C6-404D-833E-629D0A01380BQ37568315-269FF0A4-604C-4184-BEB6-2BF190BB957EQ38197714-B757DB91-32B5-4C23-BA15-2AE2E341BC63Q39019914-A4ED8577-CCE4-41EB-92BC-6985CDDB7A35Q39571357-2744EFC8-5427-4DE9-AE7D-61E83279D572Q40608363-E9A9AE11-885E-4B66-869A-DD840BAE4145Q41264625-6B3FA005-F506-453F-8F81-93273EC6ABC8Q44720880-C8AE89C7-C945-4F0B-AF19-4DDA22946A87Q49941178-5DACC8C0-43E9-4189-80FA-E296851C809FQ50065194-2D4281C7-0B3F-4C0C-8390-47C607F9A8C4Q58735789-CB24C466-A093-4699-BAE1-8F85AE46AB97
P2860
Relative safety of pooled whole blood-derived versus single-donor (apheresis) platelets in the United States: a systematic review of disparate risks.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Relative safety of pooled whol ...... tic review of disparate risks.
@en
Relative safety of pooled whole blood-derived versus single-donor
@nl
type
label
Relative safety of pooled whol ...... tic review of disparate risks.
@en
Relative safety of pooled whole blood-derived versus single-donor
@nl
prefLabel
Relative safety of pooled whol ...... tic review of disparate risks.
@en
Relative safety of pooled whole blood-derived versus single-donor
@nl
P2860
P1433
P1476
Relative safety of pooled whol ...... tic review of disparate risks.
@en
P2093
Eleftherios C Vamvakas
P2860
P304
P356
10.1111/J.1537-2995.2009.02338.X
P577
2009-08-04T00:00:00Z